Chemomab Therapeutics Ltd. Payments of Stock Issuance Costs
Chemomab Therapeutics Ltd. (CMMB) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-04-04
| Period end | Payments of Stock Issuance Costs 12 month |
|---|---|
| 2024-12-31 | $0.00 20-F · filed 2025-04-04 |
| 2023-12-31 | $0.00 20-F · filed 2025-04-04 |
| 2022-12-31 | $1.22M 20-F · filed 2025-04-04 |
| 2021-12-31 | $0.00 20-F · filed 2024-03-28 |